Universal reached back through the ages to hype Christopher Nolan‘s epic adaptation of “The Odyssey” at CinemaCon on Wednesday. Jim Orr, the studio’s distribution chief, predicted that the ...

Keith Speights has positions in Bristol Myers Squibb, Pfizer, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Bristol Myers Squibb, Pfizer, Regeneron Pharmaceuticals ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports.

4/2/25 – U.S. Rep. Jared Huffman, D-San Rafael, and state Assemblymember Chris Rogers, D-Santa Rosa, will hold a town hall Friday at Mendocino College to discuss the administration of President Donald ...

Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

research-stage immunoprotective approaches - BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several updates on the Company’s type 1 diabetes (T1D) ...

At least, that’s what you would believe if you followed the viral online fitness coach, influencer, and self-professed motivator Ashton Hall’s (@ashtonhallofficial) morning routine, which is going ...

Christopher Evans joined the photography staff at the Boston Herald in 2009 and has covered presidential elections, the NBA and Stanley Cup finals, Super Bowls, the World Series and the Pope's ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...